Report links appetite suppressants with heart disease. FDA encourages reporting of like events.
D001067:Appetite Depressants / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005277:Fenfluramine / Q000009:adverse effects*; D006349:Heart Valve Diseases / Q000139:chemically induced*; D006801:Humans; D009765:Obesity / Q000188:drug therapy; D010645:Phentermine / Q000009:adverse effects*
D001067:Appetite Depressants; D005277:Fenfluramine; D010645:Phentermine